secwatch.observer — SEC 8-K summary
======================================

Issuer:     Avalyn Pharma Inc. (AVLN)
CIK:        0001540171
Form:       8-K
Filed at:   2026-05-01T23:59:59+00:00
Accession:  0001193125-26-201434
Event type: other_material
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Avalyn Pharma adopts amended charter and bylaws upon IPO consummation
---------------------------------------------------------------------

- Authorizes 500M voting common shares and 200M non-voting common shares.
- Authorizes 10M shares of undesignated preferred stock issuable by Board.
- Eliminates all references to prior series of preferred stock.
- Establishes advance notice procedures for stockholder proposals and director nominations.
- Amendments previously disclosed in S-1 Registration Statement; effective upon IPO.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1540171/000119312526201434/0001193125-26-201434-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1540171/000119312526201434/ck0001540171-20260501.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-201434

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer